Skip to content

Clinical trials

Completed Mucopolysaccharidosis II trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis II Status: Completed Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20071
20082
20095
20102
20123
20131
20142
20154
20174
20184
20191
20202
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire14
Green Cross Corporation3
JCR Pharmaceuticals Co., Ltd.3
AO GENERIUM2
REGENXBIO Inc.2
Takeda2
ArmaGen, Inc1
Centre Hospitalier Universitaire de Liege1
Denali Therapeutics Inc.1
Duke University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis II40
Sudden Infant Death16
Lysosomal Storage Diseases11
Mucopolysaccharidoses9
Mucopolysaccharidosis I8
Mucopolysaccharidosis VI5
Metabolism, Inborn Errors3
Mucopolysaccharidosis III3
Mucopolysaccharidosis VII3
Adrenoleukodystrophy2

Trials

Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.